IRIS
FRANCO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 753
EU - Europa 516
AS - Asia 244
AF - Africa 4
SA - Sud America 3
OC - Oceania 2
Totale 1.522
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 747
IE - Irlanda 261
CN - Cina 230
FI - Finlandia 72
IT - Italia 60
DE - Germania 40
UA - Ucraina 32
GB - Regno Unito 18
BE - Belgio 16
SE - Svezia 9
CA - Canada 6
FR - Francia 4
IL - Israele 4
IN - India 4
MU - Mauritius 4
JP - Giappone 3
AU - Australia 2
SI - Slovenia 2
BR - Brasile 1
CL - Cile 1
GR - Grecia 1
ID - Indonesia 1
PE - Perù 1
PH - Filippine 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 1.522
Salva come PNG Salva come JPEG
Città #
Dublin 261
Chandler 204
Ashburn 80
Beijing 58
Ann Arbor 52
Helsinki 48
Jacksonville 42
Princeton 41
Lawrence 40
Nanjing 40
Medford 28
Wilmington 26
Hebei 24
Shanghai 23
Changsha 19
Nanchang 18
Brussels 16
Pavia 15
Woodbridge 15
Piscataway 12
Boardman 11
Jiaxing 10
Shenyang 10
Milan 9
New York 7
Seattle 7
Toronto 6
Norwalk 5
Phoenix 5
Rome 5
Washington 5
Chicago 4
Fairfield 4
Giv‘atayim 4
Guangzhou 4
Hangzhou 4
San Francisco 4
Tianjin 4
Xian 4
Crema 3
Houston 3
Tokyo 3
Turin 3
Berlin 2
Cambridge 2
Como 2
Frankfurt am Main 2
Ljubljana 2
Naples 2
Osio Sotto 2
Pune 2
Redwood City 2
Treviso 2
Athens 1
Ballabio 1
Borås 1
Castegnato 1
Council Bluffs 1
Dearborn 1
Des Moines 1
Falkenstein 1
Gunzenhausen 1
Hefei 1
Huntington Beach 1
Jinan 1
Lima 1
Livorno 1
Magenta 1
Manila 1
Melbourne 1
Montignoso 1
Newark 1
Paris 1
Rowville 1
Singapore 1
São Paulo 1
Taizhou 1
Verona 1
Walnut 1
Totale 1.232
Salva come PNG Salva come JPEG
Nome #
Development and validation of an HPLC-UV detection assay for the determination of rufinamide in human plasma and saliva. 82
Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy. on behalf of the SOPHIE Study Group. 80
Stereoselective determination of vigabatrin enantiomers in human plasma by high performance liquid chromatography using UV detection. 76
A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasma 70
A simple and rapid HPLC-UV method for the determination of retigabine in human plasma 70
Development and validation of an HPLC-UV assay for the therapeutic monitoring of the new antiepileptic drug perampanel in human plasma 57
Novel treatment options for epilepsy: Focus on perampanel 55
Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer's Disease 52
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects 51
Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium. 47
Challenges in the clinical development of new antiepileptic drugs 42
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior 41
Off-Label Prescribing of Antiepileptic Drugs in Pharmacoresistant Epilepsy: A Cross-Sectional Drug Utilization Study of Tertiary Care Centers in Italy 40
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 39
The pharmacogenomics of epilepsy 37
Antiepileptic drugs and brain maturation: Fetal exposure to lamotrigine generates cortical malformations in rats. 37
Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial 37
Author Response: Does Screening for Adverse Effects Improve Health Outcomes in Epilepsy? A Randomized Trial 37
2β-3,4-Unsaturated sialic acid derivatives: Synthesis optimization, and biological evaluation as Newcastle disease virus hemagglutinin-neuraminidase inhibitors 36
Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug Monitoring 34
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy 33
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe 33
Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures 31
Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research 31
Adverse events, placebo and nocebo effects in placebo-treated paediatric patients with refractory focal epilepsies. Analysis of double-blind studies 30
Straightforward access to 2,3- and 3,4-unsaturated derivatives of N-glycolylneuraminic acid 28
Analysis of nocebo effects of antiepileptic drugs across different conditions 27
On-Line Solid Phase Extraction High Performance Liquid Chromatography Method Coupled With Tandem Mass Spectrometry for the Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Human Serum and Saliva 24
Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy 24
Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies 23
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 22
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2 22
Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy 20
Zonisamide in the management of epilepsy in the elderly 19
Profile of pitolisant in the management of narcolepsy: Design, development, and place in therapy 18
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy 18
Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine 18
Melatonin versus Sleep Deprivation for Sleep Induction in Nap Electroencephalography: Protocol for a Prospective Randomized Crossover Trial in Children and Young Adults with Epilepsy 18
The adverse event profile of levetiracetam: A meta-analysis on children and adults 17
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations 16
Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy 14
Tolerability of new antiepileptic drugs: a network meta-analysis 13
Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 10
Peripheral Endocannabinoid Components and Lipid Plasma Levels in Patients with Resistant Migraine and Co-Morbid Personality and Psychological Disorders: A Cross-Sectional Study 9
Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine 8
Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses 8
Pharmacokinetic Interactions Between Antiseizure and Psychiatric Medications 8
Pharmacological aspects of antiseizure medications: From basic mechanisms to clinical considerations of drug interactions and use of therapeutic drug monitoring 7
Therapeutic Salivary Monitoring of Perampanel in Patients with Epilepsy Using a Volumetric Absorptive Microsampling Technique 5
Fate of melatonin orally administered in preterm newborns: Antioxidant performance and basis for neuroprotection 5
Effects of the Dual FAAH/MAGL Inhibitor AKU-005 on Trigeminal Hyperalgesia in Male Rats 4
Interplay of Modified Sialic Acid Inhibitors and the Human Parainfluenza Virus 1 Hemagglutinin-Neuraminidase Active Site 2
Solubility of lamotrigine in age-specific biorelevant media that simulated the fasted- and fed-conditions of the gastric and intestinal environments in pediatrics and adults: implications for traditional, re-formulated, modified, and new oral formulations 2
Totale 1.587
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.799
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020260 62 74 1 7 3 9 22 8 1 10 53 10
2020/2021109 8 12 4 7 11 7 2 20 4 9 16 9
2021/2022171 2 2 7 2 2 1 2 7 11 5 32 98
2022/2023640 80 62 5 35 54 44 0 36 288 7 21 8
2023/2024301 49 24 14 23 28 67 14 32 2 9 26 13
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 1.587